To test the clinical implications of PIERCE1 as a potential therapeutic strategy against lung cancer, a PIERCE1 conditional KO (cKO) mouse model was established by crossing the mice harboring the PIERCE1 KO first allele with flippase TG mice to produce a Cre-lox mouse system (Supplementary Fig. 15a) [41]. Here, PIERCE1 is linked to lung cancer.